<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36964860</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1568-5608</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Inflammopharmacology</Title><ISOAbbreviation>Inflammopharmacology</ISOAbbreviation></Journal><ArticleTitle>What is really 'Long COVID'?</ArticleTitle><Pagination><StartPage>551</StartPage><EndPage>557</EndPage><MedlinePgn>551-557</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10787-023-01194-0</ELocationID><Abstract><AbstractText>The previous acute respiratory diseases caused by viruses originating from China or the middle east (e.g., SARS, MERS) remained fast developing short diseases without major sequalae or any long-lasting complications. The new COVID-19, on the other hand, not only that it rapidly spread over the world, but some patients never fully recovered or even if they did, a few weeks later started to complain not only of shortness of breath, if any, but general weakness, muscle pains and 'brain fog', i.e., fuzzy memories. Thus, these signs and symptoms were eventually labelled 'long COVID', for which the most widely used definition is 'new signs and symptoms occurring 4-8&#xa0;weeks after recovering from acute stage of COVID-19'. The other most frequent manifestations associated with long COVID include headache, loss of memory, smell and of hair, nausea, and vomiting. Thus, long COVID is not a simple disease, but complex disorder of several organ systems malfunctioning; hence, it is probably more appropriate to call this a syndrome. The pathogenesis of long COVID syndrome is poorly understood, but initial and persistent vascular endothelial injury that often triggers the formation of microthrombi that if dislodged as emboli, damage several organs, especially in the brain, heart and kidney, by creating microinfarcts. The other major contributory mechanistic factor is the persistent cytokine storm that may last longer in long COVID patients than in others, probably triggered by aggregates of SARS-Co-2 discovered recently in the adrenal cortex, kidney and brain. The prevalence of long COVID is relatively high, e.g., initially varied 3-30%, and recent data indicate that 2.5% of UK population suffers from this syndrome, while in the US 14.7% of acute COVID-19 patients continued to have symptoms longer than 2&#xa0;months. Thus, the long COVID syndrome deserves to be further investigated, both from clinical and basic research perspectives.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Szabo</LastName><ForeName>Sandor</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1185-797X</Identifier><AffiliationInfo><Affiliation>School of Medicine, American University of Health Sciences, 1600 East Hill St., Signal Hill/Long Beach, CA, 90755, USA. sszabo@auhs.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zayachkivska</LastName><ForeName>Oksana</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>School of Medicine, American University of Health Sciences, 1600 East Hill St., Signal Hill/Long Beach, CA, 90755, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussain</LastName><ForeName>Alamdar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, American University of Health Sciences, 1600 East Hill St., Signal Hill/Long Beach, CA, 90755, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muller</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>School of Medicine, American University of Health Sciences, 1600 East Hill St., Signal Hill/Long Beach, CA, 90755, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonology, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Inflammopharmacology</MedlineTA><NlmUniqueID>9112626</NlmUniqueID><ISSNLinking>0925-4692</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Clinical manifestations</Keyword><Keyword MajorTopicYN="N">Definitions</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Pathogenesis</Keyword></KeywordList><CoiStatement>There is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>25</Day><Hour>12</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36964860</ArticleId><ArticleId IdType="pmc">PMC10039447</ArticleId><ArticleId IdType="doi">10.1007/s10787-023-01194-0</ArticleId><ArticleId IdType="pii">10.1007/s10787-023-01194-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dvorak HF, Detmar M, Claffey KP, Nagy JA, Van der Water L, Senger DL (1995) Vascular permeability factor/vascular endothelial growth actor: an important mediator pf angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 107:233&#x2013;235</Citation><ArticleIdList><ArticleId IdType="pubmed">7542074</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreier F (2022) Long-COVID symptoms less likely in vaccinated people, Israeli data say. Nature. 10.1038/d41586-022-00177-5</Citation><ArticleIdList><ArticleId IdType="pubmed">35079170</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, Luscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. 2020;41:3038&#x2013;3044. doi: 10.1093/eurheartj/ehaa623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa623</ArticleId><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochoa S (2022) How patients wrote &#x2018;the first textbook&#x2019; on long COVID. Los Angeles Times, Nov. 16</Citation></Reference><Reference><Citation>Pang J, Xu F, Aondio G, Li Y, Fumagalli A, Lu M. Efficacy and tolerability of bevacizumab in patients with severe Covid-19. Nat Commun. 2021;12:814. doi: 10.1038/s41467-021-21085-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21085-8</ArticleId><ArticleId IdType="pmc">PMC7864918</ArticleId><ArticleId IdType="pubmed">33547300</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, Safarpour A, Trujillo KL, Simonson MD, Green J, Quintana A, Druckman J, Baum MA, Lazer D (2022) Prevalence and correlates of long COVID symptoms among US adults. JAMA Network Open 5(10):e2238804</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Prior R. The Long Haul: solving the puzzle of the pandemic's long haulers and how they are changing healthcare forever. New York: Post Hill Press-Simon &amp; Schuster; 2022. p. 336.</Citation></Reference><Reference><Citation>Sahebnasagh A, Nabavi SM, Kashani HRK, Abdollahian S, Habtemariam S, Rezabakhsh A. Anti-VEGF agents: as appealing targets in the setting of COVID-19 treatment in critically ill patients. Intern Immunopharmacol. 2021;191:108257. doi: 10.1016/j.intimp.2021.108257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.108257</ArticleId><ArticleId IdType="pmc">PMC8519896</ArticleId><ArticleId IdType="pubmed">34673299</ArticleId></ArticleIdList></Reference><Reference><Citation>Selye H. A syndrome produced by diverse nocuous agents. Nature. 1936;138:132. doi: 10.1038/138032a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/138032a0</ArticleId><ArticleId IdType="pubmed">9722327</ArticleId></ArticleIdList></Reference><Reference><Citation>Selye H. Stress in health and disease. Boston: Butterworth&#x2019;s Inc.; 1976.</Citation></Reference><Reference><Citation>Slomski A (2022) Belief in having had COVID-19 linked with long COVID symptoms. JAMA 327(1):26. 10.1001/jama.2021.23318</Citation><ArticleIdList><ArticleId IdType="pubmed">34982129</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo S, Tache Y, Somogyi A. The legacy of Hans Selye and the origins of stress research: a retrospective 75 years after his landmark &#x201c;letter&#x201d; in Nature. Stress. 2012;15:472&#x2013;478. doi: 10.3109/10253890.2012.710919.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10253890.2012.710919</ArticleId><ArticleId IdType="pubmed">22845714</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo S (2020) COVID-19: new disease and chaos with panic, associated with stress. Med Sci 59:41&#x2013;62</Citation></Reference><Reference><Citation>Szabo S (2021) Vascular endothelial injury: common element in the cellular and molecular pathogenesis of GI ulceration and COVID-19. In: Proceedings of the 14th international conference cell/tissue injury and cytoprotection/cytoprotection. PECS, Hungary, p 12</Citation></Reference><Reference><Citation>The RECOVERY Collaborative Group Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693&#x2013;704. doi: 10.1056/NEJMoa2021436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Weixel N (2022) Study suggests coronavirus lingers in organs for months. https://thehill.com/policy/healthcare/587391-study-suggests-coronavirus-lingers-in-organs-for-months/</Citation></Reference><Reference><Citation>Yavropoulou MP, Tsokos GC, Chrousos GP, Sfikakis PP. Protracted stress-induced hypocortisolemia may account for the clinical and immune manifestations of Long COVID. Clin Immunol. 2022;245:109133. doi: 10.1016/j.clim.2022.109133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2022.109133</ArticleId><ArticleId IdType="pmc">PMC9519365</ArticleId><ArticleId IdType="pubmed">36182048</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>